DERMA PHARM A/S: Financial statements 2019
CVR: 89453119
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 63,481,838 and a net result of DKK 6,050,671 compared with DKK 4,649,092 the year before. That is an increase of 21.1% compared with the year before. Equity in the 2019 report amounted to DKK 32,608,874. The solvency ratio was 38.5%. The company had 105 employees in the financial year.
- Gross Profit
- DKK 63,481,838
- Profit/Loss
- DKK 6,050,671
- Equity
- DKK 32,608,874
- Total Assets
- DKK 84,620,501
- Employees
- 105
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 63.5 mio. | 6.1 mio. | 32.6 mio. | 105 |
| 2018 | - | 52.4 mio. | 4.6 mio. | 30.7 mio. | 91 |
| 2017 | - | 47.6 mio. | 8.6 mio. | 31 mio. | 71 |
| 2016 | - | 43.2 mio. | 7.8 mio. | 22.4 mio. | 62 |
| 2015 | - | 33.3 mio. | 4.3 mio. | 14.6 mio. | 56 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
DERMA PHARM A/S has published its annual report for 2018. Gross profit came to DKK 52,440,842, and the net result was DKK 4,649,092.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.